H. Michelakakis et al., CHARACTERIZATION OF GLUCOCEREBROSIDASE IN GREEK GAUCHER DISEASE PATIENTS - MUTATION ANALYSIS AND BIOCHEMICAL-STUDIES, Journal of inherited metabolic disease, 18(5), 1995, pp. 609-615
Gaucher disease is the most frequent lysosomal storage disease in Gree
ce, accounting for 24% of all lysosomal disorders diagnosed during the
last 13 years at the Institute of Child Health in Athens. The nature
of the defects in glucocerebrosidase in Greek Gaucher patients with no
n-neuronopathic (type 1) and neuronopathic (types 2 and 3) phenotypes
was investigated at the level of the glucocerebrosidase gene and enzym
e activity. Mutation analysis performed in 10/23 Gaucher patients with
different types of the disorder led to the identification of four mut
ations, N370S, L444P, R463C and D409H, comprising 75% of the investiga
ted alleles. N370S was only found in association with type I disease.
The genotype D409H/R463C was identified for the first time and was ass
ociated with the severe type 2 disorder. There was no correlation betw
een residual in vitro enzyme activity and either phenotype or genotype
. However, in cultured fibroblasts of the neuronopathic cases, glucoce
rebrosidase protein concentration was reduced and the capacity to degr
ade exogenous C6NBD-glucosylceramide was more severely impaired.